Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda

This study has been completed.

Sponsor:

Collaborator:

Novartis Pharmaceuticals

Information provided by (Responsible Party):

Amit Pandya, University of Texas Southwestern Medical Center

ClinicalTrials.gov Identifier:

NCT00599326

First received: January 10, 2008

Last updated: September 18, 2012

Last verified: September 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	April 2010
Primary Completion Date:	April 2010 (Final data collection date for primary outcome measure)

No publications provided by University of Texas Southwestern Medical Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Pandya AG, Nezafati KA, Ashe-Randolph M, Yalamanchili R. Deferasirox for porphyria cutanea tarda: a pilot study. Arch Dermatol. 2012 Aug;148(8):898-901. doi: 10.1001/archdermatol.2012.807.

To Top